1. Home
  2. METCB vs ALT Comparison

METCB vs ALT Comparison

Compare METCB & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • METCB
  • ALT
  • Stock Information
  • Founded
  • METCB 2015
  • ALT 1997
  • Country
  • METCB United States
  • ALT United States
  • Employees
  • METCB N/A
  • ALT N/A
  • Industry
  • METCB Coal Mining
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • METCB Energy
  • ALT Health Care
  • Exchange
  • METCB Nasdaq
  • ALT Nasdaq
  • Market Cap
  • METCB 442.6M
  • ALT 472.3M
  • IPO Year
  • METCB N/A
  • ALT N/A
  • Fundamental
  • Price
  • METCB $7.44
  • ALT $5.42
  • Analyst Decision
  • METCB Strong Buy
  • ALT Strong Buy
  • Analyst Count
  • METCB 3
  • ALT 7
  • Target Price
  • METCB $13.67
  • ALT $21.00
  • AVG Volume (30 Days)
  • METCB 42.0K
  • ALT 2.3M
  • Earning Date
  • METCB 05-12-2025
  • ALT 05-13-2025
  • Dividend Yield
  • METCB 11.28%
  • ALT N/A
  • EPS Growth
  • METCB N/A
  • ALT N/A
  • EPS
  • METCB N/A
  • ALT N/A
  • Revenue
  • METCB $628,275,000.00
  • ALT $20,000.00
  • Revenue This Year
  • METCB $3.65
  • ALT N/A
  • Revenue Next Year
  • METCB $19.94
  • ALT $1,557,547.90
  • P/E Ratio
  • METCB N/A
  • ALT N/A
  • Revenue Growth
  • METCB N/A
  • ALT N/A
  • 52 Week Low
  • METCB $6.01
  • ALT $3.55
  • 52 Week High
  • METCB $11.61
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • METCB 39.60
  • ALT 49.22
  • Support Level
  • METCB $7.13
  • ALT $5.15
  • Resistance Level
  • METCB $7.72
  • ALT $5.74
  • Average True Range (ATR)
  • METCB 0.44
  • ALT 0.31
  • MACD
  • METCB -0.13
  • ALT -0.06
  • Stochastic Oscillator
  • METCB 19.02
  • ALT 32.14

About METCB Ramaco Resources Inc. Class B

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: